Attempts to reduce the human immunodeficiency virus type 1 (HIV-1) reservoir and induce
antiretroviral therapy (ART)-free virologic control have largely been unsuccessful. In this …

False-negative severe acute respiratory syndrome coronavirus 2 test results can negatively
impact the clinical and public health response to coronavirus disease 2019 (COVID-19). We …

In simian-human immunodeficiency virus (SHIV)-infected non-human primates, broadly
neutralizing antibodies (bNAbs) against the virus appear to stimulate T cell immunity. To …

The Intact Proviral DNA Assay (IPDA) was developed to address the critical need for a
scalable method for intact HIV-1 reservoir quantification. This droplet digital PCR-based assay …

Given that HIV evolution and latent reservoir establishment occur continually within-host,
and that latently infected cells can persist long-term, the HIV reservoir should comprise a …

Nasopharyngeal swabs are critical to the diagnosis of respiratory infections including
coronavirus disease 2019, but collection techniques vary. We compared 2 recommended …

HIV's ability to persist during suppressive antiretroviral therapy is the main barrier to cure.
Immune-privileged tissues, such as the testes, may constitute distinctive sites of HIV …

Within-host HIV populations continually diversify during untreated infection, and this diversity
persists within infected cell reservoirs during antiretroviral therapy (ART). Achieving a better …

In order to cure human immunodeficiency virus (HIV), we need to better understand the
within-host evolutionary origins of the small reservoir of genome-intact proviruses that persist …

Quantitative viral load assays have transformed our understanding of viral diseases. They
hold similar potential to advance COVID-19 control and prevention, but SARS-CoV-2 viral …